Standout Papers

Mipomersen, an apolipoprotein B synthesis inhibitor, for l... 2000 2026 2008 2017 680
  1. Mipomersen, an apolipoprotein B synthesis inhibitor, for lowering of LDL cholesterol concentrations in patients with homozygous familial hypercholesterolaemia: a randomised, double-blind, placebo-controlled trial (2010)
    Frederick J. Raal, Raúl D. Santos et al. The Lancet
  2. Novel oral treatment of Gaucher's disease with N-butyldeoxynojirimycin (OGT 918) to decrease substrate biosynthesis (2000)
    Timothy M. Cox, Robin Lachmann et al. The Lancet
  3. Glucocerebrosidase mutations in clinical and pathologically proven Parkinson's disease (2009)
    José Brás, Emma Deas et al. Brain

Immediate Impact

6 by Nobel laureates 30 from Science/Nature 60 standout
Sub-graph 1 of 22

Citing Papers

Accurate proteome-wide missense variant effect prediction with AlphaMissense
2023 StandoutScienceNobel
Physiology and diseases of tissue-resident macrophages
2023 StandoutNature
3 intermediate papers

Works of Robin Lachmann being referenced

Glucocerebrosidase mutations in clinical and pathologically proven Parkinson's disease
2009 Standout
Substrate reduction therapy for glycosphingolipid storage disorders
2001
and 3 more

Author Peers

Author Last Decade Papers Cites
Robin Lachmann 3272 1780 1484 123 6.2k
Atul Mehta 6696 2425 3099 228 10.4k
Dominique P. Germain 7347 1695 3520 214 9.5k
Nina Raben 4035 3032 2635 114 7.9k
Renate Lüllmann‐Rauch 1777 2272 1382 104 5.2k
M. Elleder 2601 1360 861 192 4.0k
Joel Charrow 3975 1486 2780 142 6.9k
Nathalie Guffon 5025 1188 2323 136 6.3k
Gregory M. Pastores 7320 2116 3110 200 8.6k
Zohar Argov 879 3471 1385 178 6.2k
Thomas Braulke 2767 3067 1035 171 6.4k

All Works

Loading papers...

Rankless by CCL
2026